Literature DB >> 9304771

The case for cross-over trials in phase III.

S Senn.   

Abstract

Mesh:

Year:  1997        PMID: 9304771     DOI: 10.1002/(sici)1097-0258(19970915)16:17<2021::aid-sim644>3.0.co;2-e

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  1 in total

1.  A note on point estimation and interval estimation of the relative treatment effect under a simple crossover design.

Authors:  Chii-Dean Lin; Kung-Jong Lui
Journal:  Pharm Stat       Date:  2021-11-09       Impact factor: 1.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.